Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Express Scripts
Johnson and Johnson
McKesson
Dow

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

PROTONIX IV Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Protonix Iv patents expire, and what generic alternatives are available?

Protonix Iv is a drug marketed by Wyeth Pharms and is included in one NDA. There are three patents protecting this drug.

This drug has fifty-eight patent family members in forty countries.

The generic ingredient in PROTONIX IV is pantoprazole sodium. There are forty-eight drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the pantoprazole sodium profile page.

Drug patent expirations by year for PROTONIX IV
Drug Prices for PROTONIX IV

See drug prices for PROTONIX IV

Recent Clinical Trials for PROTONIX IV

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityPhase 1
Assiut UniversityPhase 2
University of Southern CaliforniaPhase 4

See all PROTONIX IV clinical trials

Recent Litigation for PROTONIX IV

Identify potential future generic entrants

District Court Litigation
Case NameDate
Nycomed GmbH v. Apotex Inc.2009-08-14
Nycomed GmbH v. Sandoz Inc.2008-05-16
ALTANA PHARMA AG v. SUN PHARMACEUTICAL INDUSTRIES, LTD.2005-04-13

See all PROTONIX IV litigation

Pharmacology for PROTONIX IV
Drug ClassProton Pump Inhibitor
Mechanism of ActionProton Pump Inhibitors
Synonyms for PROTONIX IV
(-)-Pantoprazole
102625-70-7
138786-67-1
142678-35-1
164579-32-2
1H-Benzimidazole, 5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-
1H-Benzimidazole, 5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-, sodiums salt
1H-Benzimidazole, 5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-,sodium salt
1H-Benzimidazole, 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-
1H-Benzimidazole, 6-(difluoromethoxy)-2-((S)-((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-
2-(((3,4-Dimethoxy-2-pyridinyl)methyl)-sulfinyl)-5-methyl-1H-1,3-benzimidazole
5-(Difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole sodium
5-(Difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridyl)methyl)sulfinyl)benzimidazole
5-(difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole
5-(Difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-1h-benzo[d]imidazole, sodium salt
5-(difluoromethoxy)-2-((3,4-dimethoxypyridin-2-yl)
5-(difluoromethoxy)-2-((3,4-dimethoxypyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole
5-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1H-benzimidazole
5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methanesulfinyl]-3H-1,3-benzodiazole
5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole
5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole Sodium Salt
5-(DIFLUOROMETHOXY)-2-[[(3,4-DIMETHOXY-2-PYRIDINYL)METHYL]SULFINYL]-1H-BENZIMIDAZOLE(Sodium salt form)
5-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
5-Difluoromethoxy-2-(3,4-dimethoxy-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole
5-DifluoroMethoxy-2-[(3,4-diMethoxy-2-pyridinyl)Methyl-sulfinyl]-1H-benziMidazole
5-Difluoromethoxy-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1H-benzimidazole
6-(difluoromethoxy)-2-((3,4-dimethoxypyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole
6-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridinyl)methylsulfinyl]-1H-benzimidazole
6-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1H-benzimidazole
6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methanesulfinyl]-1H-1,3-benzodiazole
6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole
6-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole Sodium Salt
6-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methane]sulfinyl}-1H-1,3-benzodiazole
6-[bis(fluoranyl)methoxy]-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole
625P707
A800593
AB0000909
AB0012612
AB01275513_02
AB01275513-01
AB2000509
AC-679
AC1L1IPJ
ACT02633
AK326135
AKOS015894910
AKOS015994677
AKOS034831879
AN-15599
Anagastra
API0003746
apo-Pantoprazole
Apton
Astropan
B-8510-29
B-8610-23/SK&F-96022-Z
B4720
BC203892
BC215353
BCP21400
BDBM50241342
BIDD:GT0003
BRD-A22380646-001-01-5
BRD-A22380646-001-02-3
BSPBio_002320
BY 1023
BY-1023
BY-1023 sodium
By-1023/SK&F-96022
C11806
C16H14F2N3NaO4S
C16H15F2N3O4S
C16H16F2N3O4S.Na
CAS-102625-70-7
CAS-138786-67-1
CCG-100980
CCG-213558
CHEBI:50270
CHEBI:7915
CHEMBL1200408
CHEMBL1502
Citrel
Controloc
Controloc Control
CPD000469592
CS-3161
CTK8E8734
D05353
DB00213
DSSTox_CID_24215
DSSTox_CID_3416
DSSTox_GSID_23416
DSSTox_GSID_44215
DSSTox_RID_77019
DSSTox_RID_80123
DTXSID4023416
DTXSID7044215
DZ-2352a
EC 600-331-6
FT-0602547
FT-0602602
GTPL7260
HMS1922H20
HMS2051L19
HMS2090H03
HMS2093F14
HMS3393L19
HMS3715D12
HSDB 7292
HY-17507
I06-0068
Inipomp
IQPSEEYGBUAQFF-UHFFFAOYSA-N
J-000744
J-516336
J10399
KB-303064
KS-00000GVT
KS-1093
L-Pantoprazole
LS-32883
LS-32884
MCULE-8988409059
MFCD00870182
MLS001424073
MLS003882559
MolPort-003-666-752
MolPort-005-933-577
MolPort-006-069-204
MolPort-006-823-953
NC00230
NCGC00095188-01
NCGC00095188-02
NCGC00095188-03
NCGC00095188-04
NCGC00095188-05
NCGC00255835-01
Nolpaza
NSC-759257
NSC759257
Pantecta
Pantecta Control
Pantoloc
Pantoloc Control
Pantoprazol
Pantoprazol [INN-Spanish]
pantoprazole
Pantoprazole (Protonix)
Pantoprazole (USAN/INN)
Pantoprazole [USAN:BAN:INN]
Pantoprazole [USAN:INN:BAN]
Pantoprazole Na
Pantoprazole Sodium
Pantoprazole Sodium [USAN]
Pantoprazole sodium hydrate
Pantoprazole Sodium Monohydrate
PANTOPRAZOLE SODIUM SALT
Pantoprazole sodium,(S)
Pantoprazole sodium;
Pantoprazole-d6 (Rac)
Pantoprazole, S-
Pantoprazolum
Pantoprazolum [INN-Latin]
Pantoprozole
Pantor
Pantorc
Pantozol
Pantozol Control
Panyocid
Peptazol
Pharmakon1600-01505818
Protium
Protonix
Protonix I.V
Protonix I.V.
Rifun
RT-014935
S-(-)-Pantoprazole
s2105
s4538
S86P671
SAM001246591
SB17368
SB17369
SBI-0206873.P001
SC-19214
SCHEMBL29465
SCHEMBL3543
SK-96022
SK&F 96022
SK&F-96022
SKF-96022
SKF96022 sodium
SMR000469592
SMR002533625
sodium 5-(Difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole
sodium 5-(difluoromethoxy)-2-((3,4-dimethoxypyridin-2-yl)methylsulfinyl)benzo[d]imidazol-1-ide
sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole sesquihydrate
sodium 5-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}benzimidazol-1-ide
Sodium-[5(difluoromethoxy)-2-[[3,4-dimethoxy-2-pyridyl)-methyl]sulfinyl]-1H-benzimidazole sesquihydrate
sodium;5-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]benzimidazol-1-ide
Somac Control
SPECTRUM1505818
SR-01000763715
SR-01000763715-3
STL451032
SX78SGO2TV
TL8000127
Tox21_111477
Tox21_111477_1
Tox21_112996
Tox21_302362
Ulcotenal
UNII-SX78SGO2TV
W-1227
YNWDKZIIWCEDEE-UHFFFAOYSA-N
Zosecta
Zurcal

US Patents and Regulatory Information for PROTONIX IV

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms PROTONIX IV pantoprazole sodium INJECTABLE;IV (INFUSION) 020988-001 Mar 22, 2001 AP RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Wyeth Pharms PROTONIX IV pantoprazole sodium INJECTABLE;IV (INFUSION) 020988-001 Mar 22, 2001 AP RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Wyeth Pharms PROTONIX IV pantoprazole sodium INJECTABLE;IV (INFUSION) 020988-001 Mar 22, 2001 AP RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for PROTONIX IV

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0166287 SPC/GB96/056 United Kingdom   Start Trial PRODUCT NAME: PANTOPRAZOLE AND ITS SALTS, HYDRATES AND HYDRATES OF ITS SALTS; REGISTERED: SE SE12131 19940506; UK 04889/0010 19960604
0166287 96C0032 Belgium   Start Trial PRODUCT NAME: PANTOPRAZOL. NATR. SESQUIHYDRAS PANTOPRAZOLE; NAT. REGISTRATION NO/DATE: 127 IS 98 F 3 19960222; FIRST REGISTRATION: SE 12131 19940506
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Mallinckrodt
Merck
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.